Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

SNO-SCIDOT Joint Conference on Therapeutic Delivery to the CNS

Abstract Deadline: July 10, 2017 11:59pm CST

Read Full Story

Registration Now OPen

SNO Annual Meeting - November 16 - 19, 2017

Read Full Story

Brain Tumor Biorepository Established

Ian's Friends Foundation, Children's Health Care of Atlanta

Read Full Story
View All News


International Meeting on Meningioma

Read Full Story


Mayo Clinic Neuroscience and Oncology Innovation Summit 2017

Read Full Story

2017 Abstract Submission Information



Submission deadline has passed.


Abstracts for the 2017 Society for Neuro-Oncology Annual Meeting are now being accepted. As you prepare to submit your abstract, please note:

  • The abstract deadline is June 12, 2017, 11:59pm CST
  • Abstracts are limited to 300 words; figures and tables are not allowed
  • Abstract titles should use sentence case (i.e., only the first letter of the title should be capitalized)
  • The body of the abstract should be in a single paragraph. If subheaders are used, they should be within that single paragraph in all-caps, not bolded (e.g., METHODS:)
  • Abstracts should be data-driven and must include this information in the body of the abstract
  • The embargo for abstracts published in the 2017 abstract supplement to SNO official journal Neuro-Oncology will lift at 7:00 AM (EST) on Monday, November 6, 2017. These abstracts will be made available at:
  • For information and special guidelines on Late-Breaking Abstracts, click here. 



Abstracts will be accepted in the following categories:


  • Angiogenesis and Invasion
  • Cell Biology
  • Cell Signaling and Signaling Pathways
  • Drug Discovery
  • Drug Resistance
  • Experimental Therapeutics-non-immunological
  • Genetics and Epigenetics
  • Immunology
  • Metabolomics
  • Pediatric Tumors-non-immunological
  • Radiobiology
  • Stem Cells
  • Tumor Microenvironment
  • Tumor Models


  • Adult Clinical Trials-Immunologic
  • Adult Clinical Trials-non-Immunologic
  • CNS Metastasis
  • Epidemiology
  • Meningioma
  • Health Outcome Measures
  • Molecular Pathology and Classification-Adult and Pediatric
  • Neuro-Cognitive Outcomes
  • Neuroimaging
  • Neurological Complications of Cancer
  • Neurotoxicity of Cancer Treatment
  • Pediatric Clinical Trials and Outcomes
  • Quality of Life